tirzepatide and semaglutide peptide or small molecule Sciences tirzepatide: what researchers need to know before ordering Compounded Tirzepatide: A Dual-Action Peptide

Was Losing Control of Obesity and Diabetes Centers for Disease Control and Prevention data shows: - Obesity prevalence crossed 43% heading into 2025 - Were projected to approach 50% by 2030 without intervention No healthcare system in the world can absorb that level of chronic disease burden

Nature 304:368371 Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE (2010) Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Semaglutide is a widely used GLP-1 with a clear, provider-guided titration pathway

Actual out-of-pocket costs depend heavily on insurance coverage and manufacturer savings programs

Cardiovascular Protection : Studies have shown that GLP-1/GIP receptor agonists can reduce the risk of major cardiovascular events, including heart attack and stroke